Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Development of rescue antiemetic guidelines for management of chemotherapy induced nausea and vomiting in paediatric patients at the RHSC, Edinburgh.

Zingel, J and Ferguson, J and Kinnear, Moira and Johnson, Julienne and Hudson, Stephen (2010) Development of rescue antiemetic guidelines for management of chemotherapy induced nausea and vomiting in paediatric patients at the RHSC, Edinburgh. [Proceedings Paper]

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

To review and update the existing local antiemetic guidelines at the Royal Hospital for Sick Children (RHSC) Haematology/Oncology Department, Edinburgh in line with current best practice and produce evidence based rescue antiemetic guidelines for the management of chemotherapy-induced nausea and vomiting (CINV) in paediatric patients with haematological/oncological malignancies. An extensive literature search on antiemetics and the management of CINV in paediatrics was undertaken and current local antiemetic guidelines from the Royal Hospital for Sick Children, Edinburgh (RHSCE) and three other UK paediatric Haematology/Oncology centres were reviewed. Semistructured questionnaires were designed and issued to doctors, pharmacist and nurses with expertise in paediatric haematology/oncology practicing at the RHSCE to obtain their opinions on the local antiemetic guidelines and the information regarding their practice in management of breakthrough/delayed and refractory CINV in paediatric patients. A multidisciplinary team discussion took place to approve the draft guidelines. The revised guidelines now include: updated prophylactic sections for acute and delayed CINV and a rescue antiemetic therapy section for breakthrough and refractory emesis for all CINV phases, treatment flow charts, drug information table for drugs used in the management of CINV and chemotherapy regime specific antiemetic guidelines. In addition, these revised guidelines ‘step up’ the antiemetic cover provided to children receiving highly emetogenic chemotherapy which have, in the past, proven difficult to manage. The revised antiemetic guidelines provide a decision support system for clinicians and other healthcare professionals in applying evidence-based antiemetic treatment strategies for the management of CINV into their practices and support the use of appropriate care to each patient. Anecdotally we believe these guidelines have improved our practice however, a formal audit requires to be undertaken to validate this belief.

Item type: Proceedings Paper
ID code: 33130
Keywords: antiemetic guidelines , treatment strategies, CINV, chemotherapy-induced nausea and vomiting , Pharmacy and materia medica
Subjects: Medicine > Pharmacy and materia medica
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
Depositing user: Pure Administrator
Date Deposited: 06 Sep 2011 12:05
Last modified: 07 Dec 2013 01:45
URI: http://strathprints.strath.ac.uk/id/eprint/33130

Actions (login required)

View Item